STOCK TITAN

Nutex Health (NUTX) outlines Fifth Circuit ruling reshaping No Surprises Act QPA rules

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Nutex Health Inc. reports that on August 11, 2026, the U.S. Court of Appeals for the Fifth Circuit, sitting en banc, issued a decision in Texas Medical Association v. HHS affecting how insurers calculate the Qualifying Payment Amount (QPA) under the No Surprises Act. The court held that insurers may not include so‑called “ghost rates” in QPA calculations and must include bonus and incentive payments, vacating key portions of a July 2021 interim final rule issued by federal Departments. Nutex, as a healthcare provider subject to No Surprises Act reimbursement and arbitration processes linked to the QPA, highlights that the court described prior inclusion of ghost rates as artificially suppressing QPAs and noted that arbitration awards exceeded the QPA in 85% of disputes. The decision directs federal Departments to create new rules consistent with the statute while allowing existing QPAs to be used in the interim through enforcement discretion.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
En banc decision date August 11, 2026 Date Fifth Circuit issued its decision in Texas Medical Association v. HHS
Interim final rule date July 2021 Month and year of the interim final rule on QPA calculation vacated in part
Arbitrations exceeding QPA 85% Court noted IDR arbitration results exceeded the QPA in 85% of arbitrations
Form signature date August 13, 2026 Date Nutex Health’s report was signed by the Chief Financial Officer
No Surprises Act regulatory
"Under the NSA, insurers and healthcare providers...must negotiate reimbursement rates"
A federal law that protects patients from unexpected out-of-network medical bills by limiting what providers and insurers can charge when care is received without a clear cost agreement. For investors, it changes how hospitals, physician groups, insurers and medical billing firms set prices, collect revenue and resolve payment disputes—similar to changing the rules of a game, it can shift revenue streams, margins and legal risk across the healthcare sector.
Qualifying Payment Amount financial
"from the calculation of the Qualifying Payment Amount (QPA) under the No Surprises Act"
ghost rates financial
"insurers may not include so-called “ghost rates” in their QPA calculations"
independent resolution (IDR) arbitration regulatory
"they may submit the dispute to an independent resolution (IDR) arbitration process"
Administrative Procedure Act regulatory
"In accordance with the Administrative Procedure Act the court upheld the district court’s vacatur"

FAQ

What did Nutex Health Inc. (NUTX) disclose about the recent court decision?

Nutex Health disclosed that the Fifth Circuit, sitting en banc, vacated key parts of a July 2021 rule governing QPA calculations under the No Surprises Act, changing how insurers must compute reimbursement benchmarks used in dispute resolution.

How does the Fifth Circuit’s ruling affect QPA calculations relevant to NUTX?

The ruling states insurers may not use “ghost rates” and must include bonus and incentive payments when calculating the QPA, which is the median contracted rate used as a central reference in reimbursement negotiations and arbitrations involving Nutex Health.

What is the Qualifying Payment Amount (QPA) described in Nutex Health’s (NUTX) filing?

The QPA is described as the median of the total maximum rates in an insurer’s contract for an item or service a provider furnishes, sorted by specialty and geographic region, and it anchors negotiations and independent dispute resolution under the No Surprises Act.

Why were “ghost rates” significant in the case highlighted by Nutex Health (NUTX)?

The vacated rule had allowed non‑negotiated placeholder “ghost rates” for services doctors never perform to be included in QPAs, which the court said artificially suppressed QPAs and contributed to arbitration awards exceeding the QPA in 85% of disputes.

What did the court say about bonus and incentive payments in QPA calculations affecting NUTX?

The court held that excluding risk sharing, bonus, penalty, or other incentive-based or retrospective payments from QPA calculations contradicted the No Surprises Act’s text and artificially deflated QPAs, so such payments must be included going forward.

What happens next for QPA rules affecting Nutex Health (NUTX)?

The court directed federal Departments to promulgate new rules consistent with the No Surprises Act and, under the Administrative Procedure Act, allowed them to use enforcement discretion so insurers may continue using existing QPAs until new calculations are implemented.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001479681FALSE00014796812026-08-112026-08-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
  
Date of Report (Date of earliest event reported): August 11, 2026
  
NUTEX HEALTH INC.
(Exact name of registrant as specified in its charter)
  
Delaware 
001-41346
11-3363609 
(State or Other Jurisdiction 
of Incorporation) 
(Commission File Number) 
(I.R.S. Employer 
Identification No.) 
  
1776 Yorktown Street, Suite 700, Houston, Texas 77056
(Address of principal executive offices) (zip code)
  
(713) 660-0557
(Registrant’s telephone number, including area code) 
  
N/A 
(Former name or former address, if changed since last report) 
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
  
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
  
Securities registered pursuant to Section 12(b) of the Act: 
  
Title of each class 
  
Trading Symbol(s) 
  
Name of each exchange on which registered 
Common Stock, $0.001 par value 
  
NUTX 
  
The NASDAQ Stock Market LLC 
  
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 8.01 Other Events.
On August 11, 2026, the Fifth Circuit Court of Appeals issued an en banc decision in Texas Medical Association v. HHS, No. 23-40605, vacating key portions of the July 2021 interim final rule (July 2021 Rule) promulgated by the Departments of Health and Human Services, Labor, and Treasury (Departments). The vacated provisions had allowed the inclusion of “ghost rates” and excluded bonus and incentive payments from the calculation of the Qualifying Payment Amount (QPA) under the No Surprises Act (NSA). A majority of the en banc court ruled that insurers may not include so-called “ghost rates” in their QPA calculations and must include bonus and incentive payments.
Under the NSA, insurers and healthcare providers (such as Nutex Health Inc.) must negotiate reimbursement rates via a process that centers on the QPA, and if the parties cannot reach an agreement, they may submit the dispute to an independent resolution (IDR) arbitration process. The QPA, as described by the court, is the median of the total maximum rates in an insurer’s contract for an item or service that a provider provides and furnishes, sorted by specialty and geographic region. The NSA authorized the Departments to refine the methods used to calculate the QPA via rulemaking.
The court upheld the district court’s vacatur of the July 2021 Rule, which had allowed the inclusion of all rates appearing on the face of the insurer’s contract, including non-negotiated placeholder rates for services a doctor never actually performs. The inclusion of such “ghost rates” artificially suppressed the resulting QPA and, according to the court, resulted in IDR arbitration results exceeding the QPA in 85% of arbitrations.
Further, the court held that the July 2021 Rule, which required insurers to exclude risk sharing, bonus, penalty, or other incentive-based or retrospective payments or payment adjustments, contravenes the plain text of the NSA and artificially deflates the QPA.
In accordance with the Administrative Procedure Act the court upheld the district court’s vacatur of the July 2021 rule, directing the Departments to exercise their enforcement discretion to allow insurers to continue using their existing QPAs until new QPAs are calculated in accordance with new rules promulgated by the Departments consistent with the NSA.




 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Date: August 13, 2026
NUTEX HEALTH INC. 
  
  
  
By: 
/s/ Jon C. Bates 
  
  
Jon C. Bates 
Chief Financial Officer 
  
  
 


Filing Exhibits & Attachments

3 documents